NQO1 and breast carcinoma: To this end, we utilized MDA-MB-231 NQO1+, MDA-MB-231 NQO1−, MDA-MB-468, and T47D breast cancer cells to test the hypothesis that β-lap and AOA combinatorial treatment synergistically reduces metabolic turnover in an NQO1 dependent manner.